Abstract
The immune system plays an important role in eliminating tumors. Accordingly, many immunotherapy protocols have been developed in attempts to boost anti-tumor immune responses in cancer patients. These trials most commonly aim at augmenting T-cell-, especially CD8+ T-cell, responses. In clinical trials performed to date, however, little correlation has been observed between parameters measured to assess cellular immune responses and clinical outcome. Thus, identification of reliable surrogate predictors for evaluation of cancer vaccine efficacy still remains to be accomplished and would be crucial for successfully pursuing clinically significant results. In this review, we discuss the role of different cellular components of the immune system in orchestrating and regulating an anti-tumor immune response, and how to reliably monitor these using polychromatic flow cytometry (FC). The increasing use of multi-parameter FC is expected to be as revolutionary for immunomonitoring as was the introduction of first generation technology. The application of this novel technology and more standardised monitoring assays should help identify biomarkers reliably distinguishing patients who respond to treatment.
Keywords: Tumor immunology, lymphocyte, immune monitoring, FACS, standardisation
Current Cancer Therapy Reviews
Title: Monitoring T Cell Responses to Cancer Immunotherapy: Can We Now Identify Biomarkers Predicting Patients Who will be Responders
Volume: 4 Issue: 2
Author(s): Evelyna Derhovanessian, Cecile Gouttefangeas, Sven Koch and Graham Pawelec
Affiliation:
Keywords: Tumor immunology, lymphocyte, immune monitoring, FACS, standardisation
Abstract: The immune system plays an important role in eliminating tumors. Accordingly, many immunotherapy protocols have been developed in attempts to boost anti-tumor immune responses in cancer patients. These trials most commonly aim at augmenting T-cell-, especially CD8+ T-cell, responses. In clinical trials performed to date, however, little correlation has been observed between parameters measured to assess cellular immune responses and clinical outcome. Thus, identification of reliable surrogate predictors for evaluation of cancer vaccine efficacy still remains to be accomplished and would be crucial for successfully pursuing clinically significant results. In this review, we discuss the role of different cellular components of the immune system in orchestrating and regulating an anti-tumor immune response, and how to reliably monitor these using polychromatic flow cytometry (FC). The increasing use of multi-parameter FC is expected to be as revolutionary for immunomonitoring as was the introduction of first generation technology. The application of this novel technology and more standardised monitoring assays should help identify biomarkers reliably distinguishing patients who respond to treatment.
Export Options
About this article
Cite this article as:
Derhovanessian Evelyna, Gouttefangeas Cecile, Koch Sven and Pawelec Graham, Monitoring T Cell Responses to Cancer Immunotherapy: Can We Now Identify Biomarkers Predicting Patients Who will be Responders, Current Cancer Therapy Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339408784310151
DOI https://dx.doi.org/10.2174/157339408784310151 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-VEGF Strategies – from Antibodies to Tyrosine Kinase Inhibitors: Background and Clinical Development in Human Cancer
Current Pharmaceutical Design Therapeutic Targets for the Management of Peripheral Nerve Injury- Induced Neuropathic Pain
CNS & Neurological Disorders - Drug Targets Physiological and Pathological Functions of Acid-Sensing Ion Channels in the Central Nervous System
Current Drug Targets The Tumor Stroma as Mediator of Drug Resistance - A Potential Target to Improve Cancer Therapy?
Current Pharmaceutical Biotechnology Mechanism of Anti-Tumor Effect by Curcumin in Hematological Malignancies
Current Pharmaceutical Analysis Mesenchymal Stem Cells: A New Generation of Therapeutic Agents as Vehicles in Gene Therapy
Current Gene Therapy The Function and Regulation of BMP6 in Various Kinds of Stem Cells
Current Pharmaceutical Design Intracellular Signaling Triggered by Formyl-Peptide Receptors in Nonphagocytic Cells
Current Signal Transduction Therapy A Review of the Primer Approximation Multiplex PCR (PAMP) Technique for Detecting Large Scale Cancer Genomic Lesions
Current Bioinformatics Subject Index To Volume 6
Central Nervous System Agents in Medicinal Chemistry Development of Amino Acid-Based Radiopharmaceuticals for Tumor Imaging
Mini-Reviews in Medicinal Chemistry Nutritional Attributes and Health Application of Seabuckthorn (<i>Hippophae rhamnoides</i> L.) – A Review
Current Nutrition & Food Science The proNGF-p75NTR-Sortilin Signalling Complex as New Target for the Therapeutic Treatment of Parkinsons Disease
CNS & Neurological Disorders - Drug Targets The Application of Peptides in Glioma: A Novel Tool for Therapy
Current Pharmaceutical Biotechnology Multiple Sclerosis, Gut Microbiota and Permeability: Role of Tryptophan Catabolites, Depression and the Driving Down of Local Melatonin
Current Pharmaceutical Design Neurological Disorders in Medical Use of <i>Cannabis</i>: An Update
CNS & Neurological Disorders - Drug Targets Arsenic Trioxide-based Nanomedicines as a Therapeutic Combination Approach for Treating Gliomas: A Review
Current Nanoscience The PIK3CA Gene as a Mutated Target for Cancer Therapy
Current Cancer Drug Targets <i>In Vitro</i> Effects of Propofol on Cytotoxic, Apoptotic and PI3K-Akt Signaling Pathway Genes on Brain Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry A Review on Medical Image Registration as an Optimization Problem
Current Medical Imaging